Authors
Latest:
Changes in the Technician ProfessionThe pharmacy technician profession is continuously evolving, with increases in medication safety standards bringing about changes in technician requirements.
Latest:
Evaluation of Dual Versus Triple Therapy for Hepatitis CIn this retrospective chart review, patients with hepatitis C had a sustained virologic response with either dual or triple therapy.
Latest:
Study: Syringe Services Program Reduced Injection-Related Risk Behaviors in HIV OutbreakThe study emphasizes the need for harm reduction interventions that include access to syringes and sterile injection equipment, in addition to comprehensive HIV prevention services.
Latest:
Women at the Forefront of PharmacyThree female leaders in pharmacy discuss the changes in this industry.
Latest:
A Computerized Asthma Outcomes Measure Is Feasible for Disease ManagementThe ASTHMA-CAT, an online, patient-based assessment measure, may facilitate asthma care management.
Latest:
Capecitabine and Warfarin Interaction: A Review of Literature and RecommendationsThe capecitabine and warfarin interaction is well documented in the literature and has earned a black box warning because of its potential severity.
Latest:
Specialty Pharmacy and DistributionThis case study from Avella Wholesale demonstrates the necessary strategies and steps for successful catering to a niche market.
Latest:
What Pharmacists Should Know About Postnasal DripNearly 40% of the total population will complain of chronic cough over the course of their lifetime.
Latest:
Medicare Part D Smoothing Program: Impact on Access and AdherenceThe discussion explores how Medicare's Part D smoothing program in 2025 might impact chronic lymphocytic leukemia patients’ access to and adherence to Bruton tyrosine kinase inhibitor therapies and how pharmacists can help navigate this new program. The session concludes with closing remarks.
Latest:
New York Giants Legend Pushes for Breast Cancer AwarenessFormer New York Giants running back Tiki Barber discusses his mother's fight against breast cancer and his advocacy for cancer awareness.
Latest:
Enterprise Collaborations Help Meet ChallengesCommunity Health Network of Indianapolis and Walgreens are leveraging each other’s strengths to design and implement programs.
Latest:
Florida PDMP Demonstrates Positive ResultsThe efficiency and value of the nation’s Prescription Drug Monitoring Programs (PDMPS) have been questioned from time to time by various groups.
Latest:
Hy-Vee Presents Annual Caregiver Award at Armada Specialty Pharmacy SummitA commonly held axiom in specialty pharmacy is that the patient is at the center of every action.
Latest:
Time to Take a Look at the Man in the MirrorThe trial of Michael Jackson's doctor will highlight the problem of prescription drug abuse, and expose systematic failures of the US health care system.
Latest:
Self-Care Measures Can Help Prevent and Treat HeadachesPharmacists can make clinical recommendations tailored to patients’ individual needs.
Latest:
Factors Associated With Employee Participation in a Value-Based Insurance Design InitiativeWe describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.
Latest:
Transitions of Care for Patients with Atrial FibrillationAtrial fibrillation, the most common cardiac arrhythmia, is strongly associated with increased morbidity and mortality and has become a major global public health challenge.
Latest:
A Sustainable Approach to DSCSA Compliance for the Long TermSpecialty pharmacies must plan carefully to ensure compliance with new supply chain rules.
Latest:
Payers' Views on the Heterogeneity of Treatment Effect in OncologyWhen making coverage decisions in oncology, payers find difficulties in translating evidence on treatment effect heterogeneity into coverage policies.
Latest:
Extremely Virulent Strain of Klebsiella pneumoniae Reaches United StatesAn extremely virulent (hypermucoviscous) strain of Klebsiella pneumoniae (K pneumoniae) that is resistant to carbapenem and colistin has been isolated for the first time from a patient in the United States.
